HealthInvest Partners AB Invests $9.69 Million in UnitedHealth Group Incorporated (NYSE:UNH)

HealthInvest Partners AB purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 18,408 shares of the healthcare conglomerate’s stock, valued at approximately $9,691,000. UnitedHealth Group comprises 7.6% of HealthInvest Partners AB’s portfolio, making the stock its biggest holding.

A number of other large investors have also recently bought and sold shares of UNH. Robbins Farley bought a new stake in UnitedHealth Group during the third quarter valued at about $25,000. Richelieu Gestion SA bought a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC lifted its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 5.3 %

Shares of NYSE:UNH traded up $23.51 during midday trading on Tuesday, reaching $469.14. 11,815,185 shares of the company were exchanged, compared to its average volume of 4,407,902. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a fifty day simple moving average of $491.15 and a two-hundred day simple moving average of $515.88. The firm has a market cap of $432.51 billion, a PE ratio of 19.66, a P/E/G ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.54 by $0.37. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Piper Sandler reduced their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Barclays assumed coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price objective for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $573.80.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.